Show simple item record

dc.contributor.authorJanson, Christeren_US
dc.contributor.authorAccordini, Simoneen_US
dc.contributor.authorCazzoletti, Luciaen_US
dc.contributor.authorCerveri, Isaen_US
dc.contributor.authorChanoine, Sen_US
dc.contributor.authorCorsico, Angeloen_US
dc.contributor.authorFerreira, D.S.en_US
dc.contributor.authorGarcia-Aymerich, Judithen_US
dc.contributor.authorGislason, Thorarinnen_US
dc.contributor.authorNielsen, Runeen_US
dc.contributor.authorJohannessen, Aneen_US
dc.contributor.authorJõgi, Rainen_US
dc.contributor.authorMalinovschi, Andreien_US
dc.contributor.authorMoratalla, Jesús Martínezen_US
dc.contributor.authorMarcon, Alessandroen_US
dc.contributor.authorPin, Isabelleen_US
dc.contributor.authorQuint, JKen_US
dc.contributor.authorSiroux, Valerieen_US
dc.contributor.authorAlmar, Enriqueen_US
dc.contributor.authorBellisario, Valeriaen_US
dc.contributor.authorFranklin, Karl A.en_US
dc.contributor.authorGullon, JAen_US
dc.contributor.authorHolm, Mathiasen_US
dc.contributor.authorHeinrich, Joachimen_US
dc.contributor.authorNowak, Dennisen_US
dc.contributor.authorSánchez-Ramos, José Luisen_US
dc.contributor.authorWeyler, Joosten_US
dc.contributor.authorJarvis, Deborahen_US
dc.PublishedJanson C, Accordini S, Cazzoletti L, Cerveri I, Chanoine, Corsico A, Ferreira, Garcia-Aymerich J, Gislason T, Nielsen R, Johannessen A, Jõgi R, Malinovschi A, Moratalla JM, Marcon A, Pin I, Quint J, Siroux V, Almar E, Bellisario V, Franklin KA, Gullon, Holm M, Heinrich J, Nowak D, Sánchez-Ramos JL, Weyler J, Jarvis D. Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III.. European Respiratory Journal Open Research (ERJ Open Research). 2019;1(5):00073-2018eng
dc.description.abstractAsthma often remains uncontrolled, despite the fact that the pharmacological treatment has undergone large changes. We studied changes in the treatment of asthma over a 20-year period and identified factors associated with the regular use of inhaled corticosteroid (ICS) treatment. Changes in the use of medication were determined in 4617 randomly selected subjects, while changes in adults with persistent asthma were analysed in 369 participants. The study compares data from three surveys in 24 centres in 11 countries. The use of ICSs increased from 1.7% to 5.9% in the general population and the regular use of ICSs increased from 19% to 34% among persistent asthmatic subjects. The proportion of asthmatic subjects reporting asthma attacks in the last 12 months decreased, while the proportion that had seen a doctor in the last 12 months remained unchanged (42%). Subjects with asthma who had experienced attacks or had seen a doctor were more likely to use ICSs on a regular basis. Although ICS use has increased, only one-third of subjects with persistent asthma take ICSs on a regular basis. Less than half had seen a doctor during the last year. This indicates that underuse of ICSs and lack of regular healthcare contacts remains a problem in the management of asthma.en_US
dc.rightsAttribution CC BY-NCeng
dc.titlePharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and IIIen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright ERS 2019
dc.source.journalEuropean Respiratory Journal Open Research (ERJ Open Research)

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY-NC
Except where otherwise noted, this item's license is described as Attribution CC BY-NC